827 related articles for article (PubMed ID: 19203466)
1. Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).
Suresh MR; Bhatnagar PK; Das D
J Pharm Pharm Sci; 2008 Apr; 11(2):1s-13s. PubMed ID: 19203466
[TBL] [Abstract][Full Text] [Related]
2. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.
Buchholz UJ; Bukreyev A; Yang L; Lamirande EW; Murphy BR; Subbarao K; Collins PL
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9804-9. PubMed ID: 15210961
[TBL] [Abstract][Full Text] [Related]
3. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
[TBL] [Abstract][Full Text] [Related]
4. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S
Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124
[TBL] [Abstract][Full Text] [Related]
5. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.
Du L; Zhao G; He Y; Guo Y; Zheng BJ; Jiang S; Zhou Y
Vaccine; 2007 Apr; 25(15):2832-8. PubMed ID: 17092615
[TBL] [Abstract][Full Text] [Related]
6. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
Faber M; Lamirande EW; Roberts A; Rice AB; Koprowski H; Dietzschold B; Schnell MJ
J Gen Virol; 2005 May; 86(Pt 5):1435-1440. PubMed ID: 15831955
[TBL] [Abstract][Full Text] [Related]
7. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
[TBL] [Abstract][Full Text] [Related]
8. Vaccine design for severe acute respiratory syndrome coronavirus.
He Y; Jiang S
Viral Immunol; 2005; 18(2):327-32. PubMed ID: 16035944
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
[TBL] [Abstract][Full Text] [Related]
10. Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus.
He Q; Manopo I; Lu L; Leung BP; Chng HH; Ling AE; Chee LL; Chan SW; Ooi EE; Sin YL; Ang B; Kwang J
Clin Diagn Lab Immunol; 2005 Feb; 12(2):321-8. PubMed ID: 15699428
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
He Y; Li J; Du L; Yan X; Hu G; Zhou Y; Jiang S
Vaccine; 2006 Jun; 24(26):5498-508. PubMed ID: 16725238
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
Yan K; Tan W; Wang H; Wang Y; Zhang X; Li Y; Ruan L
Viral Immunol; 2009 Feb; 22(1):57-66. PubMed ID: 19210229
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
Chou TH; Wang S; Sakhatskyy PV; Mboudjeka I; Lawrence JM; Huang S; Coley S; Yang B; Li J; Zhu Q; Lu S
Virology; 2005 Mar; 334(1):134-43. PubMed ID: 15749129
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.
Lv H; Wu NC; Tsang OT; Yuan M; Perera RAPM; Leung WS; So RTY; Chan JMC; Yip GK; Chik TSH; Wang Y; Choi CYC; Lin Y; Ng WW; Zhao J; Poon LLM; Peiris JSM; Wilson IA; Mok CKP
Cell Rep; 2020 Jun; 31(9):107725. PubMed ID: 32426212
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay.
Sunwoo HH; Palaniyappan A; Ganguly A; Bhatnagar PK; Das D; El-Kadi AO; Suresh MR
J Virol Methods; 2013 Jan; 187(1):72-8. PubMed ID: 22995576
[TBL] [Abstract][Full Text] [Related]
17. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
Zhou T; Wang H; Luo D; Rowe T; Wang Z; Hogan RJ; Qiu S; Bunzel RJ; Huang G; Mishra V; Voss TG; Kimberly R; Luo M
J Virol; 2004 Jul; 78(13):7217-26. PubMed ID: 15194798
[TBL] [Abstract][Full Text] [Related]
18. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection.
Du L; Zhao G; Lin Y; Chan C; He Y; Jiang S; Wu C; Jin DY; Yuen KY; Zhou Y; Zheng BJ
Vaccine; 2008 Mar; 26(13):1644-51. PubMed ID: 18289745
[TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]